Skip to main content
. 2021 Jan 12;14(1):e007022. doi: 10.1161/CIRCHEARTFAILURE.120.007022

Figure 4.

Figure 4.

Tubulin expression and post-translational modifications in patients with hypertrophic cardiomyopathy (HCM). Protein levels of α-tubulin (A), its tyrosinated (B) and detyrosinated forms (C) and desmin (D), all normalized to GAPDH, in tissue of patients with HCM. Kruskal-Wallis test with Dunn's multiple comparisons test, ****P<0.0001, ***P=0.0003 in (B), ***P=0.0009 in (D), **P=0.0074, *P=0.0437 in (A), *P=0.0499 in (B) and *P=0.0357 in (D). Average of the control group is set to 1. n(nonfailing interventricular septum [NFIVS]/HCMSMP/HCMSMN)=6/38/11 for (A), 8/36/11 for (B and C), 8/37/11 for (D). SMN indicates sarcomere mutation-negative; and SMP, sarcomere mutation-positive.